Yeast as a model for medical and medicinal research

被引:151
作者
Mager, WH
Winderickx, J
机构
[1] Free Univ Amsterdam, Fac Sci, Dept Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands
[2] Katholieke Univ Leuven, Dept Biol, B-3001 Heverlee, Belgium
关键词
D O I
10.1016/j.tips.2005.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the past, studies using the yeast Saccharomyces cerevisiae enabled major breakthroughs in the understanding of basic cellular and molecular processes. Today, the use of yeast is undergoing a 'rebirth' in both fundamental and applied research. Indeed, advances in yeast technology have paved the way for a variety of new genome-wide screening approaches. Experimental strategies using yeast aim to unravel disease-related molecular events and to discover novel medicinal compounds. In this article, the impact of yeast as an experimental tool for disease-related studies is summarized and the use of yeast in high-throughput screenings for pharmacological purposes is evaluated. The recently applied and promising approach of so-called humanized yeast systems is also discussed.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 62 条
[1]   A genome-wide screen in Saccharomyces cerevisiae reveals altered transport as a mechanism of resistance to the anticancer drug bleomycin [J].
Aouida, M ;
Pagé, N ;
Leduc, A ;
Peter, M ;
Ramotar, D .
CANCER RESEARCH, 2004, 64 (03) :1102-1109
[2]  
Aronheim A, 2001, METHOD ENZYMOL, V332, P260
[3]   Isolation of drugs active against mammalian prions using a yeast-based screening assay [J].
Bach, S ;
Talarek, N ;
Andrieu, T ;
Vierfond, JM ;
Mettey, Y ;
Galons, H ;
Dormont, D ;
Meijer, L ;
Cullin, C ;
Blondel, M .
NATURE BIOTECHNOLOGY, 2003, 21 (09) :1075-1081
[4]   Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action [J].
Baetz, K ;
McHardy, L ;
Gable, K ;
Tarling, T ;
Rebérioux, D ;
Bryan, J ;
Andersen, RJ ;
Dunn, T ;
Hieter, P ;
Roberge, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (13) :4525-4530
[5]   A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors [J].
Becker, F ;
Murthi, K ;
Smith, C ;
Come, J ;
Costa-Roldán, N ;
Kaufmann, C ;
Hanke, U ;
Degenhart, C ;
Baumann, S ;
Wallner, W ;
Huber, A ;
Dedier, S ;
Dill, S ;
Kinsman, D ;
Hediger, M ;
Bockovich, N ;
Meier-Ewert, S ;
Kluge, AF ;
Kley', N .
CHEMISTRY & BIOLOGY, 2004, 11 (02) :211-223
[6]   A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity [J].
Birrell, GW ;
Giaever, G ;
Chu, AM ;
Davis, RW ;
Brown, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12608-12613
[7]   Development of a rapid yeast estrogen bioassay, based on the expression of green fluorescent protein [J].
Bovee, TFH ;
Helsdingen, RJR ;
Koks, PD ;
Kuiper, HA ;
Hoogenboom, RLAP ;
Keijer, J .
GENE, 2004, 325 :187-200
[8]   HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma [J].
Brezniceanu, ML ;
Völp, K ;
Bösse, S ;
Solbach, C ;
Lichter, P ;
Joos, S ;
Zörnig, M .
FASEB JOURNAL, 2003, 17 (08) :1295-+
[9]   A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR) [J].
Chan, TF ;
Carvalho, J ;
Riles, L ;
Zheng, XFS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13227-13232
[10]  
Cismowski MJ, 2002, METHOD ENZYMOL, V344, P153